Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 1
1996 1
2004 1
2006 1
2009 1
2014 1
2015 2
2017 3
2018 2
2019 2
2020 4
2021 6
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ignacio bolus
Search for Ignacijo Biluš instead (1 results)
Chicago classification version 4.0© technical review: Update on standard high-resolution manometry protocol for the assessment of esophageal motility.
Fox MR, Sweis R, Yadlapati R, Pandolfino J, Hani A, Defilippi C, Jan T, Rommel N. Fox MR, et al. Neurogastroenterol Motil. 2021 Apr;33(4):e14120. doi: 10.1111/nmo.14120. Epub 2021 Mar 17. Neurogastroenterol Motil. 2021. PMID: 33729668 Free PMC article. Review.
A key feature of CCv.4.0 is the more rigorous and expansive protocol that incorporates single wet swallows acquired in different positions (supine, upright) and provocative testing, including multiple rapid swallows and rapid drink challenge. Additionally, solid bolus swal …
A key feature of CCv.4.0 is the more rigorous and expansive protocol that incorporates single wet swallows acquired in different positions ( …
Breaks in peristaltic integrity predict abnormal esophageal bolus clearance better than contraction vigor or residual pressure at the esophagogastric junction.
Rogers BD, Cisternas D, Rengarajan A, Marin I, Abrahao L Jr, Hani A, Lequizamo AM, Remes-Troche JM, Perez de la Serna J, Ruiz de Leon A, Zerbib F, Serra J, Gyawali CP. Rogers BD, et al. Neurogastroenterol Motil. 2022 Feb;34(2):e14141. doi: 10.1111/nmo.14141. Epub 2021 Mar 27. Neurogastroenterol Motil. 2022. PMID: 33772977
BACKGROUND: High-resolution impedance manometry (HRIM) evaluates esophageal peristalsis and bolus transit. We used esophageal impedance integral (EII), the ratio between bolus presence before and after an expected peristaltic wave, to evaluate predictors of bolus …
BACKGROUND: High-resolution impedance manometry (HRIM) evaluates esophageal peristalsis and bolus transit. We used esophageal impedan …
Ineffective esophageal motility and bolus clearance. A study with combined high-resolution manometry and impedance in asymptomatic controls and patients.
Zerbib F, Marin I, Cisternas D, Abrahao L Jr, Hani A, Leguizamo AM, Remes-Troche JM, Perez de la Serna J, Ruiz de Leon A, Serra J. Zerbib F, et al. Neurogastroenterol Motil. 2020 Sep;32(9):e13876. doi: 10.1111/nmo.13876. Epub 2020 May 12. Neurogastroenterol Motil. 2020. PMID: 32394518
Our aim was to determine motility patterns and symptoms associated with IEM defined as impaired bolus clearance. METHODS: To define altered bolus clearance, normal range of swallows with complete bolus transit (CBT) on high-resolution impedance manometry (HRI …
Our aim was to determine motility patterns and symptoms associated with IEM defined as impaired bolus clearance. METHODS: To define a …
Anxiety can significantly explain bolus perception in the context of hypotensive esophageal motility: Results of a large multicenter study in asymptomatic individuals.
Cisternas D, Scheerens C, Omari T, Monrroy H, Hani A, Leguizamo A, Bilder C, Ditaranto A, Ruiz de León A, Pérez de la Serna J, Valdovinos MA, Coello R, Abrahao L, Remes-Troche J, Meixueiro A, Zavala MA, Marin I, Serra J. Cisternas D, et al. Neurogastroenterol Motil. 2017 Sep;29(9). doi: 10.1111/nmo.13088. Epub 2017 May 7. Neurogastroenterol Motil. 2017. PMID: 28480513
BACKGROUND: Previous studies have not been able to correlate manometry findings with bolus perception. The aim of this study was to evaluate correlation of different variables, including traditional manometric variables (at diagnostic and extreme thresholds), esophageal sh …
BACKGROUND: Previous studies have not been able to correlate manometry findings with bolus perception. The aim of this study was to e …
Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis.
Gómez AM, Vallejo S, Ardila F, Muñoz OM, Ruiz ÁJ, Sanabria M, Bunch A, Morros E, Kattah L, García-Jaramillo M, León-Vargas F. Gómez AM, et al. J Diabetes Sci Technol. 2018 Jan;12(1):129-135. doi: 10.1177/1932296817730376. Epub 2017 Sep 20. J Diabetes Sci Technol. 2018. PMID: 28927285 Free PMC article.
This study evaluates the impact of an educational program and a basal-bolus insulin regimen on the blood glucose level control and risk of hypoglycemia in this population. ...An intervention was instituted consisting of a three-month educational program and a basal-bolu …
This study evaluates the impact of an educational program and a basal-bolus insulin regimen on the blood glucose level control and ri …
Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
Gómez AM, Imitola Madero A, Henao Carrillo DC, Rondón M, Muñoz OM, Robledo MA, Rebolledo M, García Jaramillo M, León Vargas F, Umpierrez G. Gómez AM, et al. J Diabetes Sci Technol. 2020 Mar;14(2):233-239. doi: 10.1177/1932296818823720. Epub 2019 Jan 24. J Diabetes Sci Technol. 2020. PMID: 30678495 Free PMC article.
We evaluated the incidence of hypoglycemia in patients with type 2 diabetes (T2D) treated with basal bolus insulin regimen using CGM and factors associated with hypoglycemia. ...Factors evaluated included glycemic variability analyzed during the first 6 days of basal bo …
We evaluated the incidence of hypoglycemia in patients with type 2 diabetes (T2D) treated with basal bolus insulin regimen using CGM …
Optimizing Meropenem Therapy for Severe Nosocomial Infections in Neonates.
Lima-Rogel V, Olguín-Mexquitic L, Kühn-Córdova I, Correa-López T, Romano-Aguilar M, Romero-Méndez MDC, Medellín-Garibay SE, Romano-Moreno S. Lima-Rogel V, et al. J Pharm Sci. 2021 Oct;110(10):3520-3526. doi: 10.1016/j.xphs.2021.05.019. Epub 2021 Jun 2. J Pharm Sci. 2021. PMID: 34089712
Stochastic simulations to establish initial dosing regimens to maximize the time above the MIC showed that the mean probabilities to achieve the PK/PD target (PTA) for microorganisms with a MIC of 2 and 8 g/mL were 0.8 and 0.7 following i.v. bolus of 250 and 500 mg/m(2)/do …
Stochastic simulations to establish initial dosing regimens to maximize the time above the MIC showed that the mean probabilities to achieve …
Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis.
Tabák ÁG, Anderson J, Aschner P, Liu M, Saremi A, Stella P, Tinahones FJ, Wysham C, Meier JJ. Tabák ÁG, et al. Diabetes Ther. 2020 Jan;11(1):305-318. doi: 10.1007/s13300-019-00735-7. Epub 2019 Dec 17. Diabetes Ther. 2020. PMID: 31848983 Free PMC article.
INTRODUCTION: Basal-bolus (BB) regimens are generally used to intensify basal insulin therapy in patients with type 2 diabetes (T2D) not meeting glycemic targets. ...
INTRODUCTION: Basal-bolus (BB) regimens are generally used to intensify basal insulin therapy in patients with type 2 diabetes (T2D) …
Tubocurarine and the neonate.
Bennett EJ, Ignacio A, Patel K, Grundy EM, Salem MR. Bennett EJ, et al. Br J Anaesth. 1976 Jul;48(7):687-9. doi: 10.1093/bja/48.7.687. Br J Anaesth. 1976. PMID: 1016646 Free article.
Tubocurarine, given as a single bolus, may be used safely for neuromuscular blockade in the neonate. ...
Tubocurarine, given as a single bolus, may be used safely for neuromuscular blockade in the neonate. ...
Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
Gómez AM, Henao DC, Muñoz OM, Aschner P, Yepes CA, Jojoa R, Kerguelen A, Parra D, Jaramillo P, Umpierrez GE. Gómez AM, et al. Diabetes Metab Syndr. 2021 Mar-Apr;15(2):499-503. doi: 10.1016/j.dsx.2021.02.008. Epub 2021 Feb 10. Diabetes Metab Syndr. 2021. PMID: 33662836 Free PMC article.
METHODS: Prospective, single-center cohort of adult patients diagnosed with type 2 diabetes or hyperglycemia and COVID-19 infection treated with basal bolus insulin regimen. Glycemic control was assessed with the use of intermittent Freestyle Libre flash glucose monitoring …
METHODS: Prospective, single-center cohort of adult patients diagnosed with type 2 diabetes or hyperglycemia and COVID-19 infection treated …
24 results